Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Jazz Pharmaceuticals PLC Transaction History
Fjarde Ap Fonden (The Fourth Swedish National Pensionfund)
- $8.86 Billion
- Q2 2024
A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 2,020 shares of JAZZ stock, worth $250,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,020Holding current value
$250,985% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
512Shares Held
57.5MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$764 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$759 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$310 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$261 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$242 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.79B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...